LNAI Lunai Bioworks Inc. logo

LNAI Lunai Bioworks Inc.

Healthcare
$2.26-2.62%ClosedMarket Cap: $10.2M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

-0.74

P/S

489.28

EV/EBITDA

-0.87

DCF Value

$-10.59

FCF Yield

-51.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

-360.7%

Operating Margin

-46992.0%

Net Margin

-612568.1%

ROE

892.5%

ROA

-1301.0%

ROIC

120.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$20.9K$-2.6M$
Q2 null$0.00$-1.8M$
Q1 null$0.00$2.8M$
Q4 null$0.00$-126.7M$

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

0.33

A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.

Peers